Director, Biologics Formulation Development
Dianthus Therapeutics, Inc. · Waltham, MA · 1 mo ago
RemoteRemoteManagementFull-time
About the role
We are seeking an experienced and strategic leader in formulation development to lead development activities for a new bispecific fusion protein program. This individual will be responsible for designing and advancing formulation strategies from early-stage candidate assessment through clinical development, with a strong focus on protein stability, manufacturability, and product presentation for both intravenous and subcutaneous administration.
Key Responsibilities
- Lead formulation development strategy for a new bispecific fusion protein from preclinical stage through clinical development.
- Design and execute studies to assess protein stability, aggregation, degradation pathways, viscosity, and developability under relevant formulation conditions.
- Develop liquid and, where appropriate, lyophilized formulations to support both IV and SC presentations.
- Lead excipient screening, buffer optimization, pH optimization, surfactant selection, and stress stability studies to identify robust drug product formulations.
- Drive high-concentration formulation development for subcutaneous delivery, including syringeability, injectability, and device compatibility assessments.
- Partner closely with Analytical Development to establish appropriate characterization methods for formulation screening, stability assessment, and comparability studies.
- Collaborate with Drug Substance, Process Development, Quality, Regulatory, Clinical Supply, and external CDMOs to ensure alignment between formulation strategy, manufacturability, and clinical needs.
- Provide technical leadership for drug product process development, fill-finish considerations, container closure selection, and tech transfer activities.
- Serve as the formulation subject matter expert during regulatory interactions and contribute to CMC sections of regulatory filings, including IND, IMPD, and BLA submissions.
- Evaluate and implement new technologies and platform approaches to improve formulation development capabilities for complex biologics.
Experience
- Ph.D. in Pharmaceutical Sciences, Chemistry, Chemical Engineering, Biochemistry, or a related field with 10+ years of relevant industry experience; or M.S. with 12+ years of relevant experience.
- Deep expertise in formulation development for biologics, including monoclonal antibodies, bispecific antibodies, fusion proteins, or other large-molecule therapeutics.
- Strong hands-on experience with protein stability assessment, excipient selection, buffer optimization, and formulation screening for early- and late-stage development.
- Demonstrated experience developing formulations for high-concentration biologics and supporting subcutaneous and intravenous presentations.
- Familiarity with key challenges associated with complex protein therapeutics, including aggregation, fragmentation, oxidation, deamidation, viscosity, and interfacial instability.
- Experience working with external CDMOs and managing outsourced formulation and drug product development activities.
- Strong understanding of drug product manufacturing, fill-finish operations, container closure systems, and clinical supply requirements.
- Familiarity with regulatory expectations for formulation and drug product development in biologics programs.
- Excellent leadership, communication, and project management skills, with the ability to work effectively across multidisciplinary teams.
- Prior experience supporting regulatory submissions and health authority interactions is preferred.